health commune logo

Head and Neck Cancer: Analysis and Management

238
0
Head Neck Cancer 1

Up until the present, there have been no predictive biomarkers or indicators for guiding HNSCC treatment. A survey report on precision medicine entitled, “Global Precision Medicine Market : Analysis and Forecast, 2017–2026” from BIS Research registered $43.59 billion in 2016. It is estimated to reach $141.70 billion by 2026, with an annual growth rate of 11.23%. The Personalized Medicine Coalition for diagnostic and targeted agents was $25 billion in 2015. 

“On a thumb rule, 30% of newly Cancer screened cases would account for HNSCC, the majority of men affected by it.”

Dr . . .

This exclusive content is reserved for our valued members. Kindly log in or sign up to enjoy full access and delve into the complete article.
Priya Subramani
WRITTEN BY

Priya Subramani

A post graduate in Nanotechnology, seamlessly integrates her expertise in engineering and research to craft compelling narratives that bridge the realms of science and technology, enlightening readers with her captivating writing.